DUBLIN--(BUSINESS WIRE)--Jan 13, 2021--

The "Growth Opportunities in Antibiotic-free Protein Expression Systems, Microbiome, Precision Nutrition and Immune Profiling" report has been added to ResearchAndMarkets.com's offering.

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) consists of insights across various antibiotic-free microbial protein expression systems, Immune profiling platforms, microbial therapeutics, and targeted antibacterials such as fecal microbiota transplantation and microbial skincare, phage therapy, venom as antimicrobial, novel antibiotic absorbent, and single-cell genomics platform for the microbiome. Further, it discusses point-of-care rapid diagnostic platforms for COVID-19, novel radioisotope therapy for cancer, precision nutrition, and manufacturing of clinical-grade cannabinoid.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Innovations in Life Science, Health and Wellness

  • Engene Biotech GmbH, Austria - Growth Opportunities
  • Profacgen, US - Growth Opportunities
  • Fujifilm Diosynth Biotechnologies, UK - Growth Opportunities
  • Wacker Chemie AG, Germany - Growth Opportunities
  • Immunai, US - Growth Opportunities
  • Adaptive Biotechnologies, US - Growth Opportunities
  • Da Volterra, France - Growth Opportunities
  • Armata Pharmaceuticals Inc., US - Growth Opportunities
  • Rebiotix Inc., US - Growth Opportunities
  • University of Pennsylvania, US - Growth Opportunities
  • Picodya, Israel - Growth Opportunities
  • MRM Health N.V, Belgium - Growth Opportunities
  • Rayzebio, US - Growth Opportunities
  • Sophia Genetics, Netherlands - Growth Opportunities
  • Mosa Meat, Netherlands - Growth Opportunities
  • Biomx, Israel - Growth Opportunities
  • Astarte Medical, US - Growth Opportunities
  • Fitbiomics, US - Growth Opportunities
  • Day Two, Israel - Growth Opportunities
  • Leucine Rich Bio, India - Growth Opportunities
  • Sanobiotec, Lithuania - Growth Opportunities
  • Bitbiome, Japan - Growth Opportunities
  • Innovative Genomics Institute, US - Growth Opportunities
  • Kallyope, USA - Growth Opportunities
  • Detact Diagnostics BV, Netherlands - Growth Opportunities
  • Intelligent Fingerprinting, UK - Growth Opportunities

For more information about this report visit https://www.researchandmarkets.com/r/as7zp1

View source version on businesswire.com:https://www.businesswire.com/news/home/20210113005626/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 01/13/2021 09:53 AM/DISC: 01/13/2021 09:54 AM


Copyright Business Wire 2021.

Recommended for you

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.

Thank you for reading!

Please log in, or sign up for a new account and purchase a subscription to read or post comments.